| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |